Neatos neste generasjon premium robotstøvsugere – Neato D10, D9 og D8 – lanseres på IFA 2020
Neato Robotics, en ledende leverandør av intelligente robotstøvsugere til boliger, kunngjorde i dag lanseringen av de nyeste modellene i premiumserien – Neato D10, D9 og D8 – på IFA Berlin 2020. Neatos robotstøvsugere er en uslåelig partner innen rengjøring, med klassens beste teknologi, enkelt oppsett og maskinvare som sikrer lang levetid.
Denne pressemeldingen inneholder multimedia. Se hele pressemeldingen her: https://www.businesswire.com/news/home/20200904005046/no/
Neato Robotics introduces new, premium additions to its lineup of intelligent robot vacuums at IFA Berlin 2020. (Photo: Business Wire)
«Vi kombinerte Neatos 15 års erfaring i bransjen med kundetilbakemeldinger og det aller nyeste innen robotteknologi og AI-teknologi (kunstig intelligens), og det er en glede å introdusere disse utrolige nye produktene – våre beste noensinne – for verden. Neatos nyeste serie med intelligente robotstøvsugere har en unik konstruksjon og teknologi som gir en førsteklasses brukeropplevelse. Den nye MyNeato-appen viser at vi er fokusert på å gjøre hverdagen enklere med robotteknologi», sa Neatos administrerende direktør, Thomas Nedder.
Den nye robotstøvsugeren fra Neato representerer den beste konstruksjonskvaliteten og brukeropplevelsen i klassen og utnytter fremdeles bransjens første D-formede design. Neato når frem helt inn i hjørner og kanter og sørger for en mer fullstendig rengjøring med den bredeste børsten og største støvbeholderen på markedet. Neato D10 fanger opp inntil 99,97 % av allergener og partikler som støv og hud- og håravfall helt ned til en størrelse på 0,3 mikron med markedets første True HEPA-filter. Å konfigurere en Neato har aldri vært enklere, med Bluetooth-aktivert tilkobling til Wi-Fi og strømlinjeformet seks-trinns prosess i den nye MyNeato-appen – den korteste konfigureringsprosessen i bransjen – for å komme i gang med rengjøringen med en gang.
Neato D10
Med en brukstid på inntil 150 minutter, et True HEPA-filter som fanger opp inntil 99,97 % av allergener helt ned til en størrelse på 0,3 mikron og den nyeste LaserSmartTM LIDAR-baserte teknologien, gir Neato D10 uslåelige ytelser når det gjelder rengjøring.
Neato D9
Neato D9 gjør det skitne arbeidet for deg. Med et supereffektivt HEPA-filter som fanger opp 99,5 % av støv og allergener, en brukstid på inntil 120 minutter og Neatos unike LaserSmartTM-teknologi, vil Neato rengjøre når og hvor du ønsker, selv i mørke.
Neato D8
Neato D8 leveres med den unike kvaliteten og grensesprengende teknologien du forventer fra Neato. F.eks. den største støvbeholderen, den ekstra brede børsten og den nyeste LaserSmartTM-teknologien, kombinert med bedre brukeropplevelse, brukstid på inntil 90 minutter og forbedret rengjøringseffektivitet.
Den nye produktserien kan leveres fra høsten 2020 fra forhandlerne våre over hele Nord-Amerika, Europa og Japan og i USA på NeatoRobotics.com.
Om Neato
Neato Robotics konstruerer intelligente roboter til boliger som forbedrer menneskers liv og løser reelle problemer. Neato fokuserer på å skape en virkelig personlig rengjøringsopplevelse og sørger for at roboter utvikler seg og tilpasser seg til forbrukeren. Neato fremmer innovasjon med intelligent LaserSmartTM LIDAR-basert navigasjon, kartlegging, smart home-konnektivitet og overlegen rengjøringsteknologi. Du finner mer informasjon på www.neatorobotics.com.
https://www.businesswire.com/news/home/20200904005046/no/
Contact information
Kriselle Laran
Head of Global Communications, Neato
press@neatorobotics.com
Alex Stephan
Vice President, Zeno Group
alex.stephan@zenogroup.com
Om Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Little Cinema Taps Verimatrix To Secure Hollywood’s Virtual Premiere Events30.11.2020 17:45:00 CET | Press release
Regulatory News: Verimatrix, (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that New York-based Little Cinema deployed Verimatrix Watermarking and Multi-DRM technologies for its virtual premieres and previews. A groundbreaking digital studio, Little Cinema has partnered with Netflix, ABC, CBS, HBO Max, and Warner Media to produce state-of-the-art virtual premiere events for an industry that used to rely solely on in-person debuts. To fulfill the enhanced protection requirements for this high-value early-release content, Little Cinema looked to Verimatrix and its Secure Cloud. These innovative and highly-interactive virtual streaming events have made waves in Hollywood, earning the studio recognition in BBC News, Vogue, Variety, Vanity Fair, The Hollywood Reporter, and more. “Verimatrix supplies us with the needed anti-piracy protections and overall peace of mind that Hollywood studios demand when switching to virtual events
Emory University to Host a Live Webcast With His Holiness the Dalai Lama30.11.2020 16:39:00 CET | Press release
The Center for Contemplative Science and Compassion-Based Ethics at Emory University will host a live webinar with His Holiness the Dalai Lama on Tuesday, December 8, 2020. A discussion titled “The Necessity of Compassion for the Survival of Humanity” will feature the Dalai Lama in conversation with Melani A. Walton, co-founder of the Rob and Melani Walton Foundation, and Dr. Sanjay Gupta, chief medical correspondent for CNN. (For speaker photos click here.) The webcast begins at 10:30pm ET on Dec. 8, 2020 (Dec. 9 @ 9:00am India Standard Time) and will be simulcast in 14 languages. It is FREE of charge and open to anyone who’d like to participate. Advance registration is encouraged at https://compassionshift.emory.edu. “With so many urgent concerns impacting our world, the time is right to start a global conversation about the importance of compassion,” said Lobsang Tenzin Negi, executive director of Emory University’s Center for Contemplative Science and Compassion-Based Ethics. “For
Flexjet Advances European Expansion with Delivery of First Embraer Praetor 60030.11.2020 15:03:00 CET | Press release
Flexjet Ltd., offering travelers access to the world’s most luxurious fleet of private jets, accepted delivery of the first Praetor 600 aircraft in its European-based fleet, marking a significant milestone in the expansion of the company’s global business. Flexjet is the only shared-ownership/fractional provider of the Praetor 600, part of a US$1.4 billion order for Embraer Executive Jets, a division of Embraer S.A. (NYSE: ERJ; BM&FBOVESPA: EMBR3), that was announced in October 2019. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201130005564/en/ Flexjet Embraer Praetor 600 super midsized aircraft part of the European-based Flexjet fleet. (Photo: Business Wire) European Managing Director Marine Eugène leads the team headquartered at Flexjet House in the Mayfair neighbourhood in the west end of London. In addition, Flexjet has opened facilities including a European Tactical Control Centre in the United Kingdom to coordinate f
Diamond Standard Commodity and Token to List on INX30.11.2020 15:00:00 CET | Press release
INX Limited, the blockchain-based platform for trading digital securities and cryptocurrencies, announces today that it has signed a letter of intent with Diamond Standard to list the world’s first diamond commodity—the Diamond Standard Coin. The Coin is a digital and physical asset: a standardized set of diamonds with a wireless chip enabling it to trade as a token on the INX trading platform. The availability of the Coin on the INX platform is pending regulatory approval for the $25 million initial public commodity offering. This diamond commodity makes a $1.2 trillion hard asset available to institutional investors for the first time. Diamond Standard recently announced its plan to launch an ETF on the NYSE under the ticker DIAM, and an agreement to list futures on the CME Globex via the MGEX. INX is providing an electronic spot market for the Diamond Standard Coin. Investors who acquire a Diamond Standard Token on the INX platform are transacting the physical commodity itself, and
Kymeta™ Announces Commercial Availability of its Next-Generation Antenna, Terminal, and Services Making Mobile Global30.11.2020 15:00:00 CET | Press release
Kymeta (www.kymetacorp.com)—the communications company making mobile global—announced that the Kymeta™ u8 and Kymeta Connect™ are available for government and commercial purchase after November 30, 2020, unlocking the potential of broadband satellite connectivity and cellular networks to satisfy the overwhelming demand for communications on the move. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201130005022/en/ Kymeta’s next-generation solutions are built for mobility and designed to meet the needs of global defense agencies, government, first responders, and commercial customers. Kymeta’s products and services have been field deployed for three years and the demand for the Kymeta u8 presales has already exceeded expectations. With the introduction of the Kymeta u8, the company has meaningfully increased antenna throughput and significantly reduced the total cost of ownership. Kymeta’s new products and services offer a bre
Inversago Pharma Continues to Rapidly Expand Its Leadership Team and Appoints Glenn D. Crater, MD, FCCP as Chief Medical Officer30.11.2020 14:00:00 CET | Press release
Inversago Pharma Inc. (“the Company” or “Inversago”), the peripheral CB1 blockade company, today announced it has appointed Glenn D. Crater, MD, FCCP as its Chief Medical Officer. In this position, Dr. Crater will oversee the clinical development of Inversago’s lead compound for Prader-Willi syndrome, INV-101, as well as its pipeline of other peripherally-acting CB1 inverse agonists in several other indications. “The appointment of a Chief Medical Officer is an essential element of our corporate strategy as we have entered the clinical phase with our lead compound”, said François Ravenelle, PhD, CEO and founder of Inversago Pharma. “Glenn brings a broad range of relevant experiences in all aspects of drug development and regulatory interactions and I trust he will have a strong impact on the science we develop at Inversago, helping us meet our objective: developing safe and potent inverse agonists of peripheral CB1 receptors”, added Dr. Ravenelle. “I am very excited to join Inversago a